Mind your gut microbiota for your metabolism and heart ! - a Metacardis international event 

September 28th and 29th, 2018


Friday, September 28th, 2018

Meeting registration (8.30h-10.30h)

9:00    Welcome address and introduction
           Karine Clément: The Metacardis project

9:30    MetaCardis Keynote Speaker  (Chair: Karine Clement)
           Prof Dusko Ehrlich, INRA: The history of metagenomics

10:30    Coffee Break

10:45    Diabetes and Obesity I (Chair: Fredrik Bäckhed)
             Principal investigators (25’ presentation, 5’ discussion)
             Fredrik Bäckhed: Translational approaches to delineate the role of microbiome in metabolic diseases
             Max Nieuwdorp: Using FMT to dissect the causality of gut microbiota in human metabolic disease


              Unpublished results from young investigators (15’)
             Karen Assmann: Immune cells and gut metagenomics
             Gwen Falony: Quantitative profiling of the gut microbiota – impacts for clinical research

12:30    LUNCH break

13:30    Diabetes and Obesity II (Chair: Judith Aron-Wisnewsky )
             Principal investigators (25’ presentation, 5’ discussion)
             Hervé Blottière: Commensal bacteria and the intestine
             Eugeni Belda: Integrative study of host and microbiome metabolic profiles in the transition to severe obesity and impaired metabolic health

             Results from the MetaCardis MetaTransition
             Unpublished results from young investigators (15’):
             Judith Aron-Wisnewsky: Bariatric surgery and metagenomics
             Francois Brial: Microbial metabolites in rodent models of insulin resistance

15:15    Coffee Break

15:30    Cardiovascular diseases (Chair: Oluf Pedersen)
             Principal investigators (25’ presentation, 5’ discussion)
             Oluf Pedersen:  Regulators of the human microbiome
             Kristiansen K.: The Microbiome and atherosclerosis.

              Unpublished results from young investigators (15’)
             Sebastien Fromentin: Microbiome and metabolome features of human ischaemic heart disease deconvoluted for impact of medication and co-morbidities’


17:15    Focus on Big Data (Chair: Jean-Daniel Zucker)
             Adrien Basdevant: Legal and ethical issues of big data

            Thierry Magnins & Mathieu Guillermin: Ethics embedded in MetaCardis

18:15    Evening event: Poster session with cocktail


Saturday, September 29th, 2018

9:00    Drug-related effects (Chair Rima Chakaroun)
           Principal investigators (25’ presentation, 5’ discussion)
           Peer Bork: Importance of drugs in metagenomic profiles
           Valentina Tremaroli: Metformin and diabetes

           Unpublished results from young investigators (15’)
           Sofia Forslund: Elucidating drug effects on the microbiota

10:40  Coffee Break

10:45  NAFLD/NASH (Chair: Jeroen Raes)
           Principal investigators (25’ presentation, 5’ discussion)
           Philippe Gérard: Gut microbiota and liver disease: lessons from germ-free animal models
           Marc Dumas: Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women

           Unpublished results from young investigators (15’)
           Chloe Vigliotti: Metagenomic biomarkers associated with NASH and fibrosis progression

12:15  The future of the gut microbiota in CMDs (Chair: Karine Clément)
            Eran Elinav: Future of metagenomics in metabolic diseases

13:15   Conference closing remarks by Karine Clément

13:30   Finger Lunch

Please note: last minute modifications might be necessary.


 Please register here

Go to top
JSN Blank template designed by JoomlaShine.com

Our site uses cookies. We'll assume that you are OK with this if you browse further. To find out more about the cookies we use, see our Cookie Policy.

I accept cookies from this site